Top Markets
Coin of the day
Jinling Pharmaceutical Company Limited Jinling Pharmaceutical Company Limited

Jinling Pharmaceutical Company Limited

000919
株式のランク #12123
Jinling Pharmaceutical Company Limited is a Chinese enterprise specializing in... Jinling Pharmaceutical Company Limited is a Chinese enterprise specializing in the manufacture and distribution of a diverse range of pharmaceutical products. Its key offerings include the Mailuoning injection, prescribed for the management of numerous vascular and thrombotic conditions such as thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and its sequelae, multiple forms of arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, and thrombophlebitis. The company also provides ferrous succinate tablets for the prevention and treatment of iron deficiency anemia, alongside lentinan injection used in the therapy of malignant tumors. Furthermore, Jinling Pharmaceutical offers medical health care services. The firm's operations are primarily based in Nanjing, China.
株価
$0.96947389
時価総額
$602.94M
変化(1日)
-2.34%
変化(1年)
-2.77%
CN
取引 Jinling Pharmaceutical Company Limited (000919)

カテゴリー

Jinling Pharmaceutical Company Limited(000919)の収益
Aug 2026 時点の収益 TTM: 0
Jinling Pharmaceutical Company Limited の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Jinling Pharmaceutical Company Limited の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。